In addition to stage (p < 0.05), there were no significant differences in the NKX2-1 high-level and low-level groups due to age, gender, TNM classification, race, smoking status, site of tumor and treatment (p > 0.05) (Table 2). The gene discussed is NKX2-1; the disease is neoplasm.